Common Contracts

CERTAIN INFORMATION (INDICATED BY “[…***…]”) AND SCHEDULES HAVE BEEN EXCLUDED FROM THIS AGREEMENT BECAUSE SUCH INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SHARE PURCHASE AGREEMENT

Share Purchase Agreement • March 2nd, 2020 • BeiGene, Ltd. • Pharmaceutical preparations • New York

• Contract Type
  Share Purchase Agreement
• Filed
  March 2nd, 2020
• Company
  BeiGene, Ltd.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This SHARE Purchase Agreement (the “Agreement”) is made and entered into as of October 31, 2019 (the “Signing Date”), by and between BeiGene, Ltd., an exempted company incorporated in the Cayman Islands (the “Company”), and Amgen Inc., a Delaware corporation (the “Investor”).

Certain information (indicated by “[***]”) and schedules have been excluded from this agreement because such information (i) is not material and (ii) would be competitively harmful if publicly disclosed. SHARE PURCHASE AGREEMENT By and Between Amgen...

Share Purchase Agreement • January 8th, 2020 • Amgen Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Share Purchase Agreement
• Filed
  January 8th, 2020
• Company
  Amgen Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

THIS SHARE PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of October 31, 2019 (the “Signing Date”), by and between BeiGene, Ltd., an exempted company incorporated in the Cayman Islands (the “Company”), and Amgen Inc., a Delaware corporation (the “Investor”).